This inventor holds 4 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 1999-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2007
Title: Braja Gopal Hazra: Innovator in Antifungal Drug Development
Introduction
Braja Gopal Hazra is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel antifungal agents. With a total of 4 patents to his name, Hazra is recognized for his innovative approaches to drug design.
Latest Patents
One of his latest patents is titled "Bile acid derived steroidal dimers with novel amphiphilic topology having antifungal activity." This patent addresses the urgent need for a new class of antifungal drugs that exhibit high efficacy and low toxicity. The synthesis and antifungal activity of bile acid-derived new steroidal dimers, specifically N,N-Diethylenetriamine bis [cholic acid amide] and N,N-Diethylenetriamine bis [deoxycholic acid amide], are described in this work. Another notable patent is "Mifepristone analogue, process for the preparation thereof and use thereof," which further showcases his expertise in drug development.
Career Highlights
Braja Gopal Hazra is affiliated with the Council of Scientific and Industrial Research, where he conducts research and development in the field of pharmaceuticals. His work has been instrumental in advancing the understanding of antifungal mechanisms and the design of effective therapeutic agents.
Collaborations
Hazra has collaborated with several esteemed colleagues, including Padmakar Laxman Joshi and Tirunahari Pavan Kumar. These collaborations have enriched his research and contributed to the successful development of his patented innovations.
Conclusion
Braja Gopal Hazra is a distinguished inventor whose work in antifungal drug development has the potential to make a significant impact on public health. His innovative patents reflect his commitment to addressing critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
